Belén Garijo/merckgroup.com
Jul 13, 2025, 17:58
Belén Garijo: Merck Has Secured the No. 2 Spot in the Pharma AI Readiness Index
Belén Garijo, Chair of the Executive Board and CEO of Merck, shared a post on LinkedIn:
“Proud moment for Merck Group!
We’ve secured the No. 2 spot in the Pharma AI Readiness Index – a huge congratulations to our teams for driving the strategic investments, innovation programs, and external collaborations that made this possible.
What’s our recipe for success?
- Relentless execution
- World-class talent
- Long-term vision
- A vibrant, enterprise-wide data culture
But perhaps most of all – we’re not just another pharma company using AI. We’re a globally diversified science and technology leader with an AI360 strategy.
Across markets, regions, and teams, we innovate with AI, scale through AI, AND help enable the future evolution of AI itself:
- Accelerating drug discovery, development, and manufacturing
- Boosting patient adherence with digital health platforms that patients can trust, and
- Delivering material solutions for the world’s leading semiconductor companies who will make next-gen AI models possible.
In short, there is no question: we’re at an advanced state of readiness to leverage AI today. Yet, even more importantly, we’re actively shaping what AI will become tomorrow – so it can make life healthier, brighter, and more connected for all.”
More posts featuring Belén Garijo.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 13, 2025, 17:58
Jul 13, 2025, 17:30
Jul 13, 2025, 17:26
Jul 13, 2025, 17:16
Jul 13, 2025, 17:16
Jul 13, 2025, 17:13